SCHEMBL8559513

SCHEMBL8559513

CCOC(=O)CC(C1=CN=C(c2ccccc2)[N+]1([O-])c1ccc2c(c1)CCN(C(=O)C(F)(F)F)CC2)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1B P49286 6/20 0.36
TACR1 P25103 1/20 0.34
ESR1 P03372 3/20 0.33
ESR2 Q92731 3/20 0.33
HTR1A P08908 1/20 0.32
CHRM5 P08912 1/20 0.32
SLC6A2 P23975 1/20 0.32
HRH2 P25021 1/20 0.32
ADRA1D P25100 1/20 0.32
HTR1B P28222 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR1E P28566 1/20 0.32
HRH1 P35367 1/20 0.32
HTR2B P41595 1/20 0.32
SLC6A3 Q01959 1/20 0.32
TMEM97 Q5BJF2 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
MTNR1A P48039 1/20 0.31
ALDH1A1 P00352 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4682332 0.74 ESR1 (0.50) MTNR1BESR1ESR2HTR1ACHRM5
SCHEMBL8562631 0.73 TMEM97 (0.39) MTNR1BTACR1ESR1ESR2HTR1A
SCHEMBL8897664 0.66 KMT2A (0.37) MTNR1BESR1ESR2ALDH1A1HSD17B10
SCHEMBL4680153 0.65 ESR1 (0.55) ESR1ESR2KMT2A
SCHEMBL13334504 0.65 ESR1 (0.56) ESR1ESR2ALDH1A1HSD17B10KDM4E
SCHEMBL8562326 0.64 ESR1 (0.33) MTNR1BESR1ESR2HTR1ACHRM5
SCHEMBL14677183 0.63 ESR2 (0.59) ESR1ESR2HTR1ACHRM5SLC6A2
SCHEMBL7560796 0.62 ESR1 (0.42) ESR1ESR2HTR1ACHRM5SLC6A2
SCHEMBL21834083 0.60 ESR1 (0.56) ESR1ESR2ALDH1A1TSHRMAPK1
SCHEMBL30950127 0.60 ESR1 (0.56) ESR1ESR2ALDH1A1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5827849-A HAVING INHIBITORY EFFECT ON INFLAMMATION AND BONE DEGRADATION, ANTITHROMBOTIC, ANTIAGGREGATORY AND TUMOR- OR METASTASIS-INHIBITING EFFECT KARL THOMAE GMBH (DE) 1998-10-27 US disclosed